- Home
- NKTR vs BLDE Comparison
NKTR vs BLDE Comparison
Compare NKTR & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- BLDE
- Stock Information
- Founded
- NKTR 1990
- BLDE 2014
- Country
- NKTR United States
- BLDE United States
- Employees
- NKTR N/A
- BLDE N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- BLDE Aerospace
- Sector
- NKTR Health Care
- BLDE Consumer Discretionary
- Exchange
- NKTR Nasdaq
- BLDE Nasdaq
- Market Cap
- NKTR 108.3M
- BLDE 285.2M
- IPO Year
- NKTR 1994
- BLDE N/A
- Fundamental
- Price
- NKTR $24.07
- BLDE $4.15
- Analyst Decision
- NKTR Strong Buy
- BLDE Strong Buy
- Analyst Count
- NKTR 6
- BLDE 2
- Target Price
- NKTR $81.67
- BLDE $6.25
- AVG Volume (30 Days)
- NKTR 4.8M
- BLDE 665.6K
- Earning Date
- NKTR 08-07-2025
- BLDE 08-06-2025
- Dividend Yield
- NKTR N/A
- BLDE N/A
- EPS Growth
- NKTR N/A
- BLDE N/A
- EPS
- NKTR N/A
- BLDE N/A
- Revenue
- NKTR $87,248,000.00
- BLDE $251,485,000.00
- Revenue This Year
- NKTR N/A
- BLDE $5.58
- Revenue Next Year
- NKTR N/A
- BLDE $8.56
- P/E Ratio
- NKTR N/A
- BLDE N/A
- Revenue Growth
- NKTR N/A
- BLDE 8.67
- 52 Week Low
- NKTR $6.48
- BLDE $2.35
- 52 Week High
- NKTR $37.38
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- NKTR 64.55
- BLDE 58.20
- Support Level
- NKTR $21.87
- BLDE $4.02
- Resistance Level
- NKTR $26.29
- BLDE $4.32
- Average True Range (ATR)
- NKTR 4.06
- BLDE 0.19
- MACD
- NKTR -0.06
- BLDE -0.01
- Stochastic Oscillator
- NKTR 38.83
- BLDE 73.02
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.